Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?

References

• Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010 Apr;38(4 Suppl):S512–21.
   PubMed Web of Science ®Google Scholar
• Jj F, SK B, Cm C, et al. AAAPT diagnostic criteria for acute sickle cell disease pain. J Pain. 2019 Jul;20(7):746–759.
   PubMed Web of Science ®Google Scholar
• Dampier C, Palermo TM, Darbari DS, et al. AAPT diagnostic criteria for chronic sickle cell disease pain. J Pain. 2017 May;18(5):490–498.
   PubMed Web of Science ®Google Scholar
• Fingar KR, Owens PL, Reid LD, et al. Characteristics of inpatient hospital stays involving sickle cell disease, 2000–2016: statistical brief #251. In: Healthcare cost and utilization project (HCUP) statistical briefs. Rockville (MD):Agency for Healthcare Research and Quality (US); 2006
   Google Scholar
• National Heart L, and Blood Institute. Evidence-based management of sickle cell disease: expert panel report. 2014 [Accessed Sep 16 2022]. Available from: https://www.nhlbi.nih.gov/resources/evidence-based-management-sickle-cell-disease-expert-0.
   Google Scholar
• Brandow AM, Carroll CP, Creary S, et al. American society of hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020 Jun 23;4(12):2656–2701.
   PubMed Web of Science ®Google Scholar
• Rees CA, Brousseau DC, Ahmad FA, et al. Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: a multicenter perspective. Am J Hematol. 2022 Aug 22; DOI:10.1002/ajh.26696
   Web of Science ®Google Scholar
• Colvin LA, Bull F, Hales TG. Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia. Lancet. 2019 Apr 13;393(10180):1558–1568.
   PubMed Web of Science ®Google Scholar
• Alshahrani MS, Alghamdi MA. Ketamine for sickle cell vaso-occlusive crises: a systematic review. Saudi J Med Med Sci. 2021 Jan-Apr;9(1):3–9.
   PubMed Web of Science ®Google Scholar
• Harris EM, Vilk E, Heeney MM, et al. A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease. Pediatr Blood Cancer. 2021 Jul;68(7):e28989.
   PubMed Web of Science ®Google Scholar
• Potter DE, Choudhury M. Ketamine: repurposing and redefining a multifaceted drug. Drug Discov Today. 2014 Dec;19(12):1848–1854.
   PubMed Web of Science ®Google Scholar
• Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009 Sep;10(9):895–926.
   PubMed Web of Science ®Google Scholar
• Kreutzwiser D, Tawfic QA. Expanding role of NMDA receptor antagonists in the management of pain. CNS Drugs. 2019 Apr;33(4):347–374.
   PubMed Web of Science ®Google Scholar
• Yang Y, Maher DP, Cohen SP. Emerging concepts on the use of ketamine for chronic pain. Expert Rev Clin Pharmacol. 2020 Feb;13(2):135–146.
   PubMed Web of Science ®Google Scholar
• Schwenk ES, Viscusi ER, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American society of regional anesthesia and pain medicine, the American academy of pain medicine, and the American society of anesthesiologists. Reg Anesth Pain Med. 2018 Jul;43(5):456–466.
   PubMed Web of Science ®Google Scholar
• Cohen SP, Bhatia A, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American society of regional anesthesia and pain medicine, the American academy of pain medicine, and the American society of anesthesiologists. Reg Anesth Pain Med. 2018 Jul;43(5):521–546.
   PubMed Web of Science ®Google Scholar
• Sheehy KA, Lippold C, Rice AL, et al. Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study. J Pain Res. 2017;10:787–795.
   PubMed Web of Science ®Google Scholar
• Nobrega R, Sheehy KA, Lippold C, et al. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease. Pediatr Res. 2018 Feb;83(2):445–454.
   PubMed Web of Science ®Google Scholar
• Kenney MO, Becerra B, Mallikarjunan A et al, . Early initiation of sub-anesthetic ketamine infusion in adults with vaso-occlusive crises is associated with greater reduction in sickle cell pain intensity: a single center's experience. Pain Med. 2022 Jun 16:1–8 DOI:10.1093/pm/pnac094. Available from: https://pubmed.ncbi.nlm.nih.gov/35708641/.
   PubMed Web of Science ®Google Scholar
• Sheehy KA, Muller EA, Lippold C, et al. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study [journal article]. BMC Pediatr. 2015;15(1):198.
   PubMedGoogle Scholar
• Lubega FA, DeSilva MS, Munube D, et al. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial. Scand J Pain. 2018 Jan 26;18(1):19–27.
   PubMed Web of Science ®Google Scholar
• Alshahrani MS, AlSulaibikh AH, ElTahan MR, et al. Ketamine administration for acute painful sickle cell crisis: a randomized controlled trial. Acad Emerg Med. 2022 Feb;29(2):150–158.
   PubMed Web of Science ®Google Scholar
• Myrvik MP, Burks LM, Hoffman RG, et al. Mental health disorders influence admission rates for pain in children with sickle cell disease. Pediatr Blood Cancer. 2013 Jul;60(7):1211–1214.
   PubMed Web of Science ®Google Scholar
• Bakri MH, Ismail EA, Elsedfy GO, et al. Behavioral impact of sickle cell disease in young children with repeated hospitalization. Saudi J Anaesth. 2014 Oct;8(4):504–509.
   PubMedGoogle Scholar
• Lance EI, Cannon AD, Shapiro BK, et al. Co-Occurrence of neurodevelopmental disorders in pediatric sickle cell disease. J Dev Behav Pediatr. 2021 Aug 1;42(6):463–471.
   PubMed Web of Science ®Google Scholar
• Diazgranados N, Ibrahim L, Brutsche NE, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 2010 Aug;67(8):793–802.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. 2022 Accessed 16 Sep 2022. https://clinicaltrials.gov/ct2/results?term=sickle+cell+and+ketamine&Search=Search
   Google Scholar